Jenna Barton serves as Senior Vice President, Finance at Myrtelle. She joined the company in 2021, bringing more than 15 years of financial and operational leadership experience with life science companies to her role. Most recently Jenna was Sr. Director of FP&A at Black Diamond Therapeutics where she oversaw the development of the company’s long range strategic planning, budgeting, and forecasting processes, and partnered with the executive leadership on investment prioritization for its programs. Prior to Black Diamond, Jenna was the Director of R&D Finance at Sage Therapeutics where she led a cross functional team that supported Research, Discovery, Clinical Operations and Program Management. Previously she held positions of increasing responsibility at Biogen, Philips Healthcare and Lonza Biologics. Jenna holds a B.S. in Finance from the University of New Hampshire and an MBA from Suffolk University.
Jenna feels fortunate to work in an industry where patients and families are the priority, there are opportunities to partner with other passionate professionals who are committed to drug development, and advancing science is at the forefront of what we do daily.